发明名称 COMPOUND HAVING 6-MEMBERED AROMATIC RING
摘要 <p>Disclosed is a prophylactic or therapeutic agent for schizophrenia or the like, which has a GPR52 agonistic activity. Specifically disclosed is a compound represented by formula (I) or a salt thereof. In formula (I), A represents -(CH2)n-CO-NRa- (wherein n represents an integer of 0 to 3) or -NRa-CO-; B represents a hydrogen atom, a halogen atom, a cyano group, a hydroxy group or the like; X1, X2, X3 and X4 independently represent -CRx= or -N=; Y represents -O-, -S-, -S(O)-, -S(O)2- or -NRy-; Z represents a bond, a methylene or an ethylene; Ar1 represents a 5- to 10-membered aromatic ring (excluding a thiazole) which may be substituted by at least one substituent selected from a halogen atom, an optionally halogenated C1-6 alkyl group and the like; Ar2 represents a 5- to 6-membered aromatic ring which may be substituted by at least one substituent selected from a halogen atom, an optionally halogenated C1-6 alkyl group and the like and which may be fused with an optionaly substituted 5- to 6-membered ring; and Ra, Rb, Rx and Ry independently represent a hydrogen atom, a halogen atom or the like.</p>
申请公布号 WO2009107391(A1) 申请公布日期 2009.09.03
申请号 WO2009JP00882 申请日期 2009.02.27
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED;SETOH, MASAKI;KOBAYASHI, TOSHITAKE;TANAKA, TOSHIO;BABA, ATSUO 发明人 SETOH, MASAKI;KOBAYASHI, TOSHITAKE;TANAKA, TOSHIO;BABA, ATSUO
分类号 C07D213/64;A61K31/44;A61K31/4433;A61K31/4439;A61K31/444;A61K31/505;A61K31/506;A61K31/5377;A61P25/18;A61P43/00;C07D213/65;C07D213/68;C07D213/70;C07D213/74;C07D213/75;C07D239/34;C07D239/42;C07D295/12;C07D401/12;C07D403/04;C07D403/12;C07D405/12;C07D409/12;C07D417/12 主分类号 C07D213/64
代理机构 代理人
主权项
地址